Depression
593 results
91 - 190
Tricyclic Antidepressants (TCA)- Electroconvulsive Therapy (ECT)
Methadone- Geriatric Psychiatry
- Music Interventions for Mental Health
- Cobicistat
- Monoamine Oxidase Inhibitors (MAOI)
- Zolpidem
Cobicistat- Major Depressive Disorder
- Efavirenz
- Somatic Symptom Disorder
- Methylphenidate
- Phenelzine
- Efavirenz
- Nefazodone
- Tranylcypromine
Metoclopramide- Toxicity & side effects: switching therapy
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
- Rilpivirine
- Rilpivirine
- Amphetamine
- Headache
- Disruptive Mood Dysregulation Disorder
- Other Antidepressants
- Second-Generation Neuroleptics
- Female Sexual Dysfunction
- Dysthymia
- Delusions
- Acetylcysteine
- Desipramine
- Nortriptyline
- Glucagonoma
- Breathing-Related Sleep Disorders
- Gabapentin
- HIV-associated neurocognitive disorder (HAND)
- Tobacco-Related Disorders
- Trazodone
- Ramelteon
- Memantine
- Naltrexone
- Meditative Therapies and Type 2 Diabetes
- Ketamine
- Benzodiazepines
- Raltegravir
- Raltegravir
O. Joseph Bienvenu, M.D., Ph.D.- Impramine
- Cycloserine
- Eating Abnormalities
- Alzheimer Disease
- Sleep Disruption
- Delafloxacin
- Sleep Aids
- Supportive Psychotherapy
- Opioid-Related Disorders
- Amitryptyline
- Clomipramine
- Oppositional Defiant Disorder
- Physical Activity and Exercise
- Cognitive Behavioral Therapy (CBT)
- Antidepressants
- Post-Traumatic Stress Disorder
- Race and Cultural Disparities in Diabetes
- Other Antidepressants
- Separation Anxiety Disorder
- Schizotypal Personality Disorder
- Peramivir
- Sertraline
- Fluoxetine
- Fexinidazole
- Adjustment Disorder
- Panic Disorder
- Social Anxiety Disorder
- Chronic Traumatic Encephalopathy
- Mindfulness During COVID-19
- Narcotic Analgesics
- Substance or Medication-Induced / Due to Another Medical Condition
- Attention-Deficit / Hyperactivity Disorder
- Naltrexone/Buproprion
- Loxapine